Mouse behavior, measured automatically.

Mouse Data devices record your behavioral tests and Mouse Data Lab analyzes them, from automated classic tests to complex behavior evaluated by Digital Researchers.

Research groups working with Mouse Data
Built by scientists. Trusted by the scientific community.

Mouse Data automates behavioral testing in mice. Our devices standardize how every experiment is recorded, and Mouse Data Lab turns each recording into objective, reproducible data.

Mouse Data Lab

The cloud platform every device connects to: record, analyze and share your experiments.

Digital Researchers

The AI that evaluates complex behavior in the video recorded by our Digital Research (DR) Systems.

Proprietary Devices

Standardized hardware for each behavioral test: the same camera, lighting and conditions in every lab.

Mouse Data Lab

One platform for every device

Every Mouse Data system connects to Mouse Data Lab. Record your sessions, get the results in the cloud, keep every experiment traceable and share it with your team.

Mouse Data Lab dashboard on a tablet
Digital Researchers

From human criteria to digital criteria

For complex behavior, such as spontaneous pain, our DR Systems use a Digital Researcher: an AI that evaluates the recorded video and applies the same criterion to every new recording.

Researchers observing mice in the lab
Proprietary Devices

The same conditions in every lab

Standardized hardware for each behavioral test: the same camera, lighting and conditions in every lab, so your results are comparable from one study to the next.

Face Analyzer device
Reinventing Behavioral Science ·
Reinventing Behavioral Science ·
Reinventing Behavioral Science ·
Contact us
INSIGHTS

Discover our publications

Papers
Pain Outcome Determines the Sensitivity to Peripheral Opioid Antagonism of Morphine, Ibuprofen, and Their Combination in Laparotomized Mice

Face Analyzer technology measured ongoing pain from facial expression after abdominal surgery.

Papers
Cold receptor TRPM8 as a target for migraine-associated pain and affective comorbidities

Face Analyzer technology detected pain-like facial expressions in mice lacking TRPM8.

Papers
Minocycline Prevents the Development of Key Features of Inflammation and Pain in DSS-induced Colitis in Mice
Papers
Sigma-1 receptor antagonism as a promising strategy for postoperative pain treatment

Face Analyzer technology measured pain at rest from facial expression after abdominal surgery.

Papers
Pharmacological differences in postoperative cutaneous sensitivity, pain at rest, and movement-induced pain in laparotomized mice

Face Analyzer technology measured pain at rest from facial expression, alongside skin sensitivity and movement-induced pain.

Researchers using Face Analyzer

We don't say it, researchers do

"The Face Analyzer has significantly enhanced the way we approach behavioral studies. One of the greatest challenges in our field is the inherent subjectivity as well as the time and cost required for manual observation. This tool provides an objective, automated metric that allows us to standardize our protocols across different studies, which is a real game-changer in the lab for pain studies. Because it’s observer-free, the Face Analyzer gives us unprecedented access to the animal's natural pain state, something which was not achievable in the lab using standard evoked measurements. It has proven to be a reliable platform for obtaining high-quality behavioral data, enabling us to advance our research with a much clearer understanding of the animal's affective state."

Shane J. Cronin

University Assistant of University of Vienna

"Face Analyzer's key strength lies in detecting spontaneous, non-induced pain expressions, which better reflect the true clinical experience of migraine patients compared to traditional reflex tests. This technology has played a crucial role in our migraine and orofacial pain research by enabling precise measurement of pain-related facial grimaces. It offers a reliable, objective way to assess how well new treatments work, marking an important advancement in the preclinical testing of novel pain relievers."

Prof. Antonio Ferrer-Montiel

Department of Biochemistry and Molecular Biology, Miguel Hernández University, Alicante, Spain

"The Face Analyzer has been a game changer for our research on a novel analgesic drug candidate. Thanks to this non-evoked approach, we were able to demonstrate that our compound not only reduces sensory hypersensitivity at the injury site (commonly measured with assays such as von Frey), but also alleviates ongoing pain, in the absence of external stimulation. Measuring ongoing pain in mice is extremely challenging because they cannot verbally communicate their discomfort. The Face Analyzer enabled us to detect subtle pain-related facial expressions that would otherwise remain unnoticed, providing critical insights into the true analgesic potential of our therapy beyond traditional evoked pain tests."

Santiago Vázquez Cruz

Professor, Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine, University of Barcelona, Spain

"The Face Analyzer is proving to be a highly valuable tool in our R&D processes. In the complex field of drug development, having a system that provides objective and automated data is a significant advantage. It allows us to obtain more reliable results and gain clearer insights into therapeutic efficacy, helping us move forward with greater confidence in the development of new treatments. It is a practical and effective solution for any lab looking to optimize their behavioral assessments."

Daniel Zamanillo

Head of Preclinical Pharmacology · ONESTX (Olavide Neuron STX SL). Seville, Spain

"The Face Analyzer has significantly enhanced the way we approach behavioral studies. One of the greatest challenges in our field is the inherent subjectivity as well as the time and cost required for manual observation. This tool provides an objective, automated metric that allows us to standardize our protocols across different studies, which is a real game-changer in the lab for pain studies. Because it’s observer-free, the Face Analyzer gives us unprecedented access to the animal's natural pain state, something which was not achievable in the lab using standard evoked measurements. It has proven to be a reliable platform for obtaining high-quality behavioral data, enabling us to advance our research with a much clearer understanding of the animal's affective state."

Shane J. Cronin

University Assistant of University of Vienna

"Face Analyzer's key strength lies in detecting spontaneous, non-induced pain expressions, which better reflect the true clinical experience of migraine patients compared to traditional reflex tests. This technology has played a crucial role in our migraine and orofacial pain research by enabling precise measurement of pain-related facial grimaces. It offers a reliable, objective way to assess how well new treatments work, marking an important advancement in the preclinical testing of novel pain relievers."

Prof. Antonio Ferrer-Montiel

Department of Biochemistry and Molecular Biology, Miguel Hernández University, Alicante, Spain

"The Face Analyzer has been a game changer for our research on a novel analgesic drug candidate. Thanks to this non-evoked approach, we were able to demonstrate that our compound not only reduces sensory hypersensitivity at the injury site (commonly measured with assays such as von Frey), but also alleviates ongoing pain, in the absence of external stimulation. Measuring ongoing pain in mice is extremely challenging because they cannot verbally communicate their discomfort. The Face Analyzer enabled us to detect subtle pain-related facial expressions that would otherwise remain unnoticed, providing critical insights into the true analgesic potential of our therapy beyond traditional evoked pain tests."

Santiago Vázquez Cruz

Professor, Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine, University of Barcelona, Spain

"The Face Analyzer is proving to be a highly valuable tool in our R&D processes. In the complex field of drug development, having a system that provides objective and automated data is a significant advantage. It allows us to obtain more reliable results and gain clearer insights into therapeutic efficacy, helping us move forward with greater confidence in the development of new treatments. It is a practical and effective solution for any lab looking to optimize their behavioral assessments."

Daniel Zamanillo

Head of Preclinical Pharmacology · ONESTX (Olavide Neuron STX SL). Seville, Spain

Stay updated with the latest in digital behavioral research